We are live on ! Find out more
DI

DAGCO Inc Portfolio holdings

AUM $541M
1-Year Est. Return 29.31%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+29.31%
3 Year Est. Return
+66.54%
5 Year Est. Return
+76.11%
10 Year Est. Return
–
AUM
$225M
AUM Growth
+$5.73M
Cap. Flow
+$3.16M
Cap. Flow %
1.4%
Top 10 Hldgs %
53.67%
Holding
232
New
13
Increased
59
Reduced
47
Closed
13

Top Buys

Rank Stock Value
1
TRV icon
Travelers Companies
TRV
+$1.39M
2
SPTS icon
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
+$731K
3
CRM icon
Salesforce
CRM
+$671K
4
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$278K
5
QQQ icon
Invesco QQQ Trust
QQQ
+$247K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$193K
2
DGRO icon
iShares Core Dividend Growth ETF
DGRO
+$161K
3
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$143K
4
NEE icon
NextEra Energy
NEE
+$135K
5
NKE icon
Nike
NKE
+$95.3K

Sector Composition

Rank Sector Weight
1 Technology 9.72%
2 Financials 5.5%
3 Healthcare 4.53%
4 Industrials 4.21%
5 Communication Services 2.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDNS icon
201
Cadence Design Systems
CDNS
$91.6B
$3.08K ﹤0.01%
10
– –
STM icon
202
STMicroelectronics
STM
$43.1B
$2.76K ﹤0.01%
70
– –
ADSK icon
203
Autodesk
ADSK
$51.8B
$2.48K ﹤0.01%
10
– –
YUMC icon
204
Yum China
YUMC
$15.7B
$2.47K ﹤0.01%
80
– –
PYPL icon
205
PayPal
PYPL
$49.9B
$2.32K ﹤0.01%
40
– –
UBER icon
206
Uber
UBER
$145B
$2.18K ﹤0.01%
30
– –
SHEL icon
207
Shell
SHEL
$244B
$2.17K ﹤0.01%
30
– –
SVM
208
Silvercorp Metals
SVM
$2.02B
$2.04K ﹤0.01%
607
– –
TSM icon
209
TSMC
TSM
$1.94T
$1.9K ﹤0.01%
11
– –
CCL icon
210
Carnival Corporation Ltd
CCL
$38.1B
$1.87K ﹤0.01%
100
– –
ZG icon
211
Zillow
ZG
$7.85B
$1.8K ﹤0.01%
40
– –
PANW icon
212
Palo Alto Networks
PANW
$256B
$1.7K ﹤0.01%
+10
New +$1.5K
MRVL icon
213
Marvell Technology
MRVL
$147B
$1.63K ﹤0.01%
23
– –
GFI icon
214
Gold Fields
GFI
$28.8B
$1.49K ﹤0.01%
100
– –
QRVO icon
215
Qorvo
QRVO
$7.9B
$1.16K ﹤0.01%
10
– –
SONY icon
216
Sony
SONY
$137B
$863 ﹤0.01%
50
– –
GILD icon
217
Gilead Sciences
GILD
$165B
$848 ﹤0.01%
12
-10
-45% -$667
CRSP icon
218
CRISPR Therapeutics
CRSP
$4.69B
$702 ﹤0.01%
13
– –
CVS icon
219
CVS Health
CVS
$135B
$532 ﹤0.01%
9
-700
-99% -$43.8K
BE icon
220
Bloom Energy
BE
$48.2B
– –
-1,123
Closed -$12.6K
BMY icon
221
Bristol-Myers Squibb
BMY
$129B
– –
-3,550
Closed -$193K
CIM
222
Chimera Investment
CIM
$1.06B
– –
-167
Closed -$2.31K
CNTY icon
223
Century Casinos
CNTY
$32.9M
– –
-328
Closed -$1.04K
DNUT icon
224
Krispy Kreme
DNUT
$562M
– –
-260
Closed -$3.96K
FSM icon
225
Fortuna Silver Mines
FSM
$2.54B
– –
-800
Closed -$2.98K
6 7 8
9
10

Similar funds

CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
BCB
Brian C. Broderick $542M AUM 20.28% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
FF
Francis Financial $539M AUM 14.16% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $539M AUM 31.72% 1-Year Est. Return
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return

DAGCO Inc's Q2 2024 Portfolio in Review

As of Q2 2024, DAGCO Inc held 232 positions worth $225M, up 2.6% from $220M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

DAGCO Inc's Q2 2024 filing shows 13 new, 59 increased, 47 reduced and 13 closed positions. Its largest new stake was Travelers Companies: 6,467 shares worth $1.32M. The largest sale was Bristol-Myers Squibb, an estimated $193K.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.6% a quarter earlier, followed by Financials and Healthcare.

  • DAGCO Inc's largest Q2 2024 buy was Travelers Companies: 6,467 shares worth $1.32M.
  • DAGCO Inc added most to State Street SPDR Portfolio Short Term Treasury ETF in Q2 2024, an estimated $731K increase.
  • DAGCO Inc's biggest Q2 2024 reduction was iShares Core Dividend Growth ETF, cutting an estimated $161K.
  • DAGCO Inc fully exited Bristol-Myers Squibb in Q2 2024, selling an estimated $193K.
  • DAGCO Inc's ten largest holdings make up 54% of its $225M portfolio in Q2 2024.
  • DAGCO Inc opened 13 new positions and closed 13 in Q2 2024.
  • DAGCO Inc's portfolio value rose 2.6% quarter-over-quarter to $225M.

Based on DAGCO Inc's 13F filing for Q2 2024, filed 14 Aug 2024.